Synjardy XR 1000 mg/1

Synjardy XR 1000 mg/1 is an extended-release tablet combining empagliflozin and metformin hydrochloride. It is designed to help manage type 2 diabetes by improving blood sugar control. This medication is suitable for adults and is taken orally.

Synjardy XR 1000 mg/1 is primarily used for the management of type 2 diabetes in adults. It works by combining two active ingredients, empagliflozin and metformin hydrochloride, to help control blood sugar levels. This medication is often prescribed as part of a comprehensive treatment plan that includes diet and exercise. People often ask, 'What is Synjardy XR used for?' and the answer is that it is designed to improve glycemic control in individuals with type 2 diabetes.

Common effects of Synjardy XR 1000 mg/1 may include symptoms such as nausea, diarrhea, and headache. Some individuals may experience urinary tract infections or hypoglycemia, especially when combined with other diabetes medications. It is important to monitor blood sugar levels regularly while taking this medication.

Synjardy XR 1000 mg/1 should be handled with care. It is important to follow the prescribed dosage and administration instructions provided by a healthcare professional. This medication should be stored at room temperature and kept out of reach of children. Individuals with certain medical conditions, such as kidney problems, should consult their healthcare provider before using this medication.

Synjardy XR 1000 mg/1 may interact with other medications, including certain diabetes drugs, diuretics, and some antibiotics. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol consumption should be limited while taking this medication, as it can increase the risk of side effects.